is There an Effect of Adding Body Vibration to Intake of Vitamin D on Some Outcomes of Familial Mediterranean Fever
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: whole body vibration plus usual care, usual care.
- Who it may be relevant to
- Registry conditions: Familial Mediterranean Fever. Basic parameters: 13 years — 17 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
is There an Effect of Addition of Body Vibration to Intake of Vitamin D on Some Outcomes of Familial Mediterranean Fever
Overview
Familial mediterranean fever (FMF) is common in mediterranean region. this disorder is connected with deterioration in functional performance, fitness of cardiorespiration, muscle strength, and bone mass
Detailed description
Familial mediterranean fever (FMF adolescent girls ) will be collected to be cateogarized to vibration group (vibration group) or control grouping. every group OF FMF will contain 20 FMF adolescent girls. both groups will receive vitamin D and their traditional colchicine doses daily for six months. vibration group will receive three sessions of 20-min whole body vibration in the week for 6 months
Interventions
- Other whole body vibration plus usual care
Familial mediterranean fever (20 FMF adolescent girls ) will be in this vibration group who will receive vitamin D and their traditional colchicine doses daily for six months. vibration group will also receive three sessions of 20-min whole body vibration in the week for 6 months - Other usual care
Familial mediterranean fever (20 FMF adolescent girls ) will be in this control group who will receive vitamin D and their traditional colchicine doses daily for six months.
Primary outcome measures
- bone mineral density [Time frame: it will be measured after 6 months]
Secondary outcome measures (7)
- z score [Time frame: it will be measured after 6 months]
- vitamin D [Time frame: it will be measured after 6 months]
- osteoprotegerin [Time frame: it will be measured after 6 months]
- quadriceps torque [Time frame: it will be measured after 6 months]
- Standing long jump test [Time frame: it will be measured after 6 months]
- Thirty second sit to stand test [Time frame: it will be measured after 6 months]
- Ruffier index [Time frame: it will be measured after 6 months]
Eligibility criteria
Inclusion criteria
FMF adolecent girls ages 13 -17 years forty patients
Exclusion criteria
cardiac problems renal problems liver problems diabetes brain problems
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Cairo University — Giza
Identifiers
NCT: NCT07130305 · IRB00014233-33